Open Access Open Access
Restricted Access Subscription Access


The aim of research: to synthesize the gene, coding the non-toxic variant of diphtheria toxin CRM197, to explore its expression in Escherichia coli cells, to construct bacterial strain - producer of recombinant CRM197 and to develop the method for purification of this CRM197 protein from the biomass of bacteria. Materials and methods of research. the gene of CRM197 was synthesized by chemical and enzymatic methods. Expression vector pColdII-CRM197 construction and assembly were performed by standard genetic engineering methods. CRM197 production by Escherichia coli cells was explored by electrophoresis in polyacrylamide gel and immunoblotting. The recombinant CRM197 was purified with the use of metal-chelate chromatography. Results. The application of the pColdII expression vector made possible to produce recombinant protein after decrease of the cell cultivation temperature from 37° C to 16° C. The method for purification of CRM197 recombinant protein was developed and the protein preparation with the purity 97% was obtained, having molecular mass 60 kDa; this protein was coupled with polyclonal antibodies against diphtheria toxin in the immunoblot. Conclusion. Successful production of CRM197 recombinant protein was reached with the use of pColdII vector at the decreased cell cultivation temperature. The purified CRM197 demonstrated nuclease activity pointing its proper folding. Production of the purified recombinant CRM197 protein allows its use for development of new conjugate vaccines.

I V Dukhovlinov

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

E G Bogomolova

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

O V Dobrovolskaya

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

CA A Ishuk

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

EA A Fedorova

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

N A Klimov

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

A S Simbirtsev

FSUE «State Research Institute for Highly Pure Biopreparations» FMBA of the Russian Federation

corresponding member of the Russian Academy of Sciences

  1. Lory S., Carroll S.F., Collier R.J. Ligand interactions of diphtheria toxin. II. Relationships between the NAD site and the P site // J. Biol. Chem. 1980. Vol. 255, No 24. P. 12016-12019.
  2. Uchida T, Pappenheimer A.M., Greany R. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin // J. Biol. Chem. 1973. Vol. 248, No 11. P. 3838-3844.
  3. Durando P, Faust S.N., Fletche M, Krizova P, Torres A., Welte T. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults // Clin. Microbiol. Infect. 2013. Vol. 19 (suppl. 1). P. 1$9.
  4. Avci F.Y, Li X., Tsuji M, Kasper D.L. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design // Nat. Med. 2011. Vol. 17, No 12. P. 1602-1609.
  5. Burtnick M.N., Shaffer T.L., Ross B.N., Muruato L.A., Sbrana E, DeShazer D, Torres A.G., Brett P.J. Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis // Infect. Immun. 2017. Nov. 6. pii: IAI.00724-17. doi: 10.1128/ IAI.00724-17.
  6. Ilyina N, Kharit S., Namazova-Baranova L., Asatryan A., Benashvili M., Tkhostova E., Bhusal C., Arora A.K. Safety and immunogenicity of meningococcal ACWYCRM197-conjugate vaccine in children, adolescents and adults in Russia // Hum. Vaccin. Immunother. 2014. Vol. 10, No 8. P. 2471-2481.
  7. Allison E.B., Turner J.E., Gerson H.Y, So, D.J., Krasznai A.J., Hilaire S, Gerson D.F. Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae // Synth. Syst. Biotechnol. 2017. Vol. 2, No 1. P. 49$58.
  8. Dateoka S., Ohnishi Y., Kakudo K. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer // Med. Mol. Morphol. 2012. Vol. 45, No 2. P. 91-97.
  9. Dateoka S., Kakudo K. CRM197, a specific inhibitor of HB-EGF // Med. Mol. Morphol. 2013. Vol. 415, No 1. P. 83-87.
  10. Schenk G.J., Haasnoot P.C., Centlivre M., Legrand N., Rip J., de Boer A.G., Berkhout B. Efficient CRM197-mediated drug targeting to monocytes // J. Control. Release 2012. Vol. 158, No 1. P. 139-147.
  11. Rappuoli R. Isolation and characterization of Corynebacterium diphtheria nontandem double lysogens hyperproducing CRM197 // Appl. Environ. Microbiol. 1983. Vol. 46, No 3. P. 560-564.
  12. Zhou J., Petracca R. Secretory expression of recombinant diphtheria toxin mutants in B. Subtilis // J. Tongji Med. Univ. Tong Ji Yi Ke Xue Xue Bao. 1999. Vol. 19, No 4. P. 253-256.
  13. Retallack D.M., Jin H., Chew L. Reliable protein production in a Pseudomonas fluorescens expression system // Protein Expr. Purif. 2012. Vol. 81, No 2. P. 157-165.
  14. Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin // Gene. 1992. Vol. 110, No 1. P. 89-94.
  15. Studier FW. Stable expression clones and auto-induction for protein production in E. coli // Methods Mol Biol. 2014. Vol. 1091, No 1. P. 17-32.
  16. Laemmly U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 // Nature. 1970. No 227. P. 680-685.
  17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. // J. Biol. Chem. 1951. Vol. 193, No 1. P. 265 -275.
  18. Phadtare S., Severinov K. RNA remodeling and gene regulation by cold shock proteins // RNA Biol. 2010. Vol. 7, No 6. P. 788-795.
  19. Takara Cold Shock Expression System pCold™ DNA. Product Manual.
  20. Chang M.P., Baldwin R.L., Bruce C., Wisnieski B.J. Second cytotoxic pathway of diphtheria toxin suggested by nuclease activity // Science. 1989. Vol. 246, No 4934. P. 1165-1168.
  21. Bruce C., Baldwin R.L., Lessnick S.L., Wisnieski B.J. Diphtheria toxin and its ADP-ribosyltransfer-ase-defective homologue CRM197 possess deoxyribonuclease activity // Proc. Nati. Acad. Sci. USA. 1990. Vol. 87, No 8. P. 2995-2998.
  22. Jia B., Co J. High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives // Open Biol.2016. Vol. 6, No 8. pii: 160196. doi: 10.1098/rsob.160196.
  23. Srnrensen H.P, Mortensen K.K. Advanced genetic strategies for recombinant protein expression in Escherichia coli // J. Biotechnol. 2005. Vol. 115, No 2. Р. 113-128.
  24. Peleg Y, Unger T. Application of high-throughput methodologies to the expression of recombinant proteins in E. coli // Methods Mol. Biol. 2008. Vol. 426. P. 197-208.


Abstract - 149

PDF (Russian) - 0



  • There are currently no refbacks.

Copyright (c) 2018 Dukhovlinov I.V., Bogomolova E.G., Dobrovolskaya O.V., Ishuk C.A., Fedorova E.A., Klimov N.A., Simbirtsev A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.